The U.S. Supreme Court has declined to review the Ninth Circuit’s decision involving a $53 million breach of contract case between C.R. Bard Inc. and Atrium Medical Corp. The dispute centers on allegations of patent royalties and patent misuse, as originally advocated by C.R. Bard Inc.
The case has drawn significant attention due to its potential implications on how patent royalties are enforced in contractual agreements. For more details, the comprehensive outline of the case proceedings can be accessed through Law360.